Analyzing inoculum effect and optimal design of antibiotic treatment
Duke University, Durham NC
Investigators
Linked publications & trials
Abstract
DESCRIPTION (provided by applicant): Antibiotics have been hailed as the single most significant therapeutic discovery in medicine. However, they have become increasingly ineffective due to emergence of antibiotic resistant bacteria. In addition to developing new antibiotics, there is a critical need to design better treatment protocols using existing antibiotics. Achieving this goal will require a better understanding of the myriad of ways by which bacteria can resist or tolerate antibiotic treatment at the level of individuals or populations. A common phenomenon of bacterial tolerance is the inoculum effect: for a given concentration of an antibiotic, its ability to inhibit bacterial growth decreases with the size of the bacterial inoculum. Its occurrence is often considered undesirable in the clinical setting: it can increase mortality rates of infected host due to insufficient dose of antibiotics and cause overestimation of bacterial resistance. However, the underlying mechanism by which the inoculum effect occurs remains poorly understood. For an antibiotic targeting the protein synthesis machinery (the ribosome), our preliminary analysis suggests that: (1) a critical determinant of inoculum effect is fast degradation of the ribosomal components induced by the antibiotic via the heat shock response; (2) the inoculum effect can drastically affect efficacy of antibiotic treatment. Our proposed research aims to examine these hypotheses by using a translational approach that integrates mathematical modeling, in vitro study, and in vivo study in the animal model of bacterial infections. It is our vision that the proposed work will generate mechanistic understanding of inoculum effect and lead to design of effective treatment strategies against pathogens that exhibit inoculum effect. These outcomes would represent a significant step toward more effective use of existing antibiotics to treat bacterial infections.
View original record on NIH RePORTER →